Press Release RenovoRx Reports Record Second Quarter 2026 Results, Driven by Accelerating Commercial Adoption and 61% Sequential Quarterly Revenue Growth RenovoRx, Inc. · Aug 12
Press Release Royalty Pharma and Zealand Pharma enter into rusfertide funding agreement for $100 million Royalty Pharma plc · Aug 12
Press Release Spero Therapeutics Announces Second Quarter 2026 Operating Results and Provides Business Update Spero Therapeutics, Inc. · Aug 12
Press Release Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update Connect Biopharma Holdings Limited · Aug 12
Press Release Core Molding Technologies to Host Investor Day on September 29-30, 2026, Including Tour of Matamoros, Mexico Manufacturing Facility Core Molding Technologies, Inc. · Aug 12
Press Release OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance OptimizeRx Corporation · Aug 12
Press Release Lumexa Imaging Announces Second Quarter 2026 Results Lumexa Imaging Holdings, Inc. · Aug 12
Press Release Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights Journey Medical Corporation · Aug 12
Press Release INOVIO Reports Second Quarter 2026 Financial Results and Recent Business Highlights INOVIO Pharmaceuticals, Inc. · Aug 12
Press Release Outlook Therapeutics Announces Proposed Public Offering of Common Stock and Warrants Outlook Therapeutics, Inc. · Aug 12
Press Release AGNC Investment Corp. Declares Monthly Common Stock Dividend of $0.12 per Common Share for August 2026 AGNC Investment Corp. · Aug 12